Te­va joins fel­low phar­mas in re­strict­ing 340B dis­counts

Te­va is the lat­est in a long list of drug­mak­ers plac­ing re­stric­tions around the fed­er­al 340B pro­gram which pro­vides dis­count­ed drugs for low-in­come Amer­i­cans.

Ac­cord­ing to a let­ter ac­quired by the non­prof­it 340B Health, Te­va an­nounced Thurs­day that start­ing Ju­ly 5, cov­ered hos­pi­tals with in-house out­pa­tient phar­ma­cies will no longer be el­i­gi­ble to have 340B-dis­count­ed med­i­cines shipped to con­tract phar­ma­cies. End­points News has con­firmed the con­tent of the let­ter with Te­va.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER